Cipla launches etanercept biosimilar
The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership
)
Explore Business Standard
The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership
)
Drugmaker Cipla Ltd said on Wednesday it has launched etanercept biosimilar in India under the brand name Etacept.
The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership, it said in a statement.
First Published: Apr 17 2013 | 4:54 PM IST